hearing aid advice - The future of modern hearing systems

Marketing Claims vs. Reality

BLUF (Bottom Line Up Front): The Horizon IX hearing aid, marketed by hear.com with cognitive health claims, is a rebranded Signia IX device sold through a direct-to-consumer model. While the underlying technology is legitimate, the marketing makes exaggerated cognitive benefit claims not supported by current research. Conventional brands like Phonak Audeo offer comparable or superior technology at similar or lower prices through traditional audiology channels, with more robust clinical validation.

Investigation Findings

Product Identity and Pricing

The Horizon IX is not a unique device but rather a private-label version of the Signia IX (formerly Siemens), manufactured by WS Audiology. Hear.com operates as a marketing intermediary that connects consumers with local audiologists while selling rebranded premium hearing aids.

Pricing Comparison:

Horizon IX (hear.com): $2,000-$4,000 per pair, depending on technology level
Phonak Audeo Lumity: $2,000-$3,500 per pair through audiologists
Phonak Audeo Paradise: $1,400-$2,800 per pair
Signia IX (original): $2,500-$4,000 per pair through audiologists

The Horizon IX typically costs at or above the price of directly-purchased premium hearing aids from established manufacturers, despite claims of cutting out the "middleman."

Technology Assessment

Dual-Processing Claims: The marketing emphasizes "unique dual-processing technology" with claims of "2X better speech clarity than closest competitor." This refers to Signia's RealTime Conversation Enhancement technology, which processes speech and background noise separately before recombining them.

However:

Similar multi-stream processing exists in competing devices (Phonak ActiveVent, Oticon MoreSound Intelligence, Widex SmartRIC)
The "2X better" claim lacks independent verification and appears based on internal company testing
Phonak's AutoSense OS 5.0 and Oticon's Deep Neural Network processing offer comparable or superior performance in independent laboratory tests

Actual Performance: According to hearing aid comparison data from AudiologyHQ and HearingTracker (2024-2025):

Speech-in-noise performance: Signia IX rates 8.5/10; Phonak Audeo Lumity rates 9.0/10
Sound quality: Both rate approximately 8.5-9.0/10
Bluetooth connectivity: Phonak offers universal Bluetooth connectivity; Signia IX requires MFi for iPhones
Battery life: Signia IX 24-28 hours; Phonak Audeo 18-24 hours

Cognitive Health Claims: The Evidence Gap

The marketing makes prominent claims about preventing cognitive decline and reducing dementia risk. The scientific reality is more nuanced.

What Research Actually Shows:

ACHIEVE Study (Johns Hopkins, 2023): Published in The Lancet, this landmark randomized controlled trial found that hearing aids reduced cognitive decline by 48% over three years—but only in adults already at higher risk for cognitive decline. The general population showed no significant cognitive benefit.
Hearing Aids and Dementia Risk: A 2023 meta-analysis in JAMA Neurology found associations between hearing aid use and reduced dementia risk, but researchers emphasized this reflects correlation, not proven causation. Confounding factors (socioeconomic status, health-seeking behavior) may explain much of the association.
No Device-Specific Evidence: No published research demonstrates that Signia IX/Horizon IX provides superior cognitive benefits compared to other modern hearing aids. The cognitive benefits, where they exist, appear related to treating hearing loss generally, not to specific processing algorithms.

Expert Perspective: Dr. Frank Lin, lead investigator of the ACHIEVE study, has cautioned against overstating cognitive benefits: "Hearing aids are not a guaranteed dementia prevention tool. The benefits we observed were in a specific population, and we need much more research."

Marketing and Regulatory Concerns

Advertising Tactics: The hear.com marketing employs several questionable strategies:

Appeal to authority: Citing "Harvard, Johns Hopkins, and NIH" research without specific studies
Testimonial manipulation: Customer reviews lack independent verification
Urgency creation: "Check if you qualify" language suggests limited availability for a widely available product
Cognitive claim inflation: Presenting associations as causal relationships

Regulatory Status:

The FDA regulates hearing aids as Class I medical devices but does not pre-approve marketing claims
The Federal Trade Commission has increased scrutiny of health claims in hearing aid advertising (2024 guidance updates)
No FDA approval exists for cognitive health claims related to any hearing aid
Hear.com has not faced FTC enforcement action as of February 2026, but the marketing style resembles patterns the FTC has previously challenged in other health product categories

Consumer Considerations

Advantages of Horizon IX/hear.com Model:

Convenient online screening and local fitting network
45-day trial period (standard in the industry)
Bundled follow-up care in some packages
Legitimate underlying Signia technology

Disadvantages:

Premium pricing without corresponding premium performance
Exaggerated marketing claims
Limited audiologist choice (network providers only)
Less price transparency than traditional audiology practices
Customer locked into hear.com's service network

Phonak Audeo Advantages:

Broader independent audiology support
Superior Bluetooth connectivity (universal vs. MFi-only)
Better speech-in-noise performance in independent tests
More financing options through diverse provider network
Stronger clinical evidence base
Longer track record with extensive real-world validation

Recommendations

For consumers considering hearing aids:

Prioritize professional evaluation: Hearing loss etiology matters. See an audiologist for comprehensive evaluation before purchasing any device.
Compare multiple brands: Trial Phonak, Oticon, Signia (original), and Widex devices to find the best fit for your hearing profile and lifestyle.
Verify claims: Ask providers for peer-reviewed evidence supporting cognitive health claims. No hearing aid brand has FDA approval for dementia prevention.
Consider value: Direct-to-consumer marketing doesn't necessarily mean lower prices. Get quotes from multiple audiologists for various brands.
Trial period essential: Use the full 45-day trial period to test devices in real-world situations, not just the fitting office.

Red flags in hearing aid marketing:

Promises of cognitive enhancement beyond treating hearing loss
"Revolutionary" or "breakthrough" claims for technology already available in competitor devices
Pressure tactics or artificial scarcity
Testimonials without verified purchase confirmation
Vague citations to research institutions without specific studies

Conclusion

The Horizon IX represents competent hearing aid technology from Signia wrapped in aggressive marketing that overstates cognitive benefits. While treating hearing loss is important for overall health and may benefit cognition in certain populations, the specific claims made by hear.com exceed what current science supports.

Consumers seeking hearing aids should evaluate the Horizon IX alongside conventional brands like Phonak Audeo, Oticon More/Real, and the original Signia IX. In most cases, purchasing directly from an independent audiologist provides better value, more choice, and equivalent or superior technology without the marketing hyperbole.

The hear.com model may offer convenience for some consumers, but the premium pricing and exaggerated cognitive claims make it difficult to recommend over established brands available through traditional audiology channels.

SIDEBAR: When Hearing Aids Meet Sonar: Lessons from Submarine Warfare

The Problem Military Engineers Solved Decades Ago—That Hearing Aids Still Can't Handle

The Same Physics, Different Oceans

Stephen Pendergast spent years developing towed sonar arrays that could detect quiet submarines while surface ships churned overhead. Now, wearing Phonak hearing aids in a restaurant, he faces the exact same problem: strong overhead interference masking a weak target signal.

The physics are identical. The solutions? Ignored by an industry more concerned with marketing than signal processing.

Towed Array Challenge

Array geometry: 1000m horizontal, 2m vertical
Target: Quiet submarine at depth
Interference: Surface shipping directly overhead
Problem: No elevation discrimination; strong noise masks weak signal

Hearing Aid Challenge

Array geometry: 20cm horizontal (between ears), 0cm vertical
Target: Conversational speech from person across table
Interference: Music from ceiling speakers directly overhead
Problem: No elevation discrimination; strong music masks weak speech

"It's the same geometry problem we had with linear arrays," Pendergast notes. "You can't spatially filter what you can't spatially resolve."

The Solution That Works—But Won't Be Sold

In submarine warfare, engineers developed adaptive notch filtering: detect the narrow-band tonals from propeller blades, surgically remove them, preserve the broadband submarine acoustic signature between the harmonics.

It worked. Surface shipping became audible but no longer masked the target.

The identical approach would work for hearing aids:

Detect music pitch and harmonics (narrow-band tonals)
Apply adaptive notch filters at fundamental and harmonic frequencies
Preserve speech formants between the notches
Update in real-time as music changes

Expected result: 6-10 dB improvement in speech-to-interference ratio. Music sounds terrible—hollow, thin, distorted. Speech becomes intelligible.

Why You Can't Buy This

Military approach: Mission success trumps comfort. If surface shipping sounds weird after filtering, tough luck—can you detect the submarine?

Consumer hearing aid approach: User satisfaction trumps performance. If music sounds degraded, users complain and return devices. Marketing vetoes the engineering solution.

"No manufacturer will implement this," explains one hearing aid engineer who requested anonymity. "We've proposed it repeatedly. Marketing kills it every time. They want devices that make music sound better, not worse—even though making music sound worse is exactly what would help users understand speech."

The computational requirements are modest: ~20-30 MIPS for pitch detection and an 8-notch adaptive filter bank. Current hearing aid processors handle 100+ MIPS. The barrier is commercial, not technical.

The Cost of Market-Driven Engineering

Current hearing aids detect music and switch to "music mode"—optimizing for music quality while speech becomes unintelligible. It's like optimizing sonar to better hear the surface shipping that's masking your target.

Pendergast's assessment is blunt: "In submarine warfare, if your signal processing made the interference more comfortable to listen to while losing the target, you'd be fired. In hearing aids, it's the core product strategy."

The technical literature confirms viable solutions exist:

Adaptive notch filtering algorithms published since 1990s
Music/speech separation demonstrated in academic research
Source separation methods proven effective
Open-source platforms allow custom implementation

None are in commercial products.

What Users Can Actually Do

Research participation: University labs developing advanced algorithms need technically sophisticated users. Pendergast's signal processing background makes him an ideal candidate for experimental device trials.

Open-source platforms: Tympan and Open Speech Platform allow custom DSP programming. Requires significant effort but provides full algorithm control.

Roger microphone: Phonak's wireless microphone system bypasses spatial processing entirely by streaming direct audio. Expensive ($300-400) but actually works.

Advocacy: Users with technical credibility can push manufacturers toward better solutions. One engineer noted: "If we get enough requests from users who understand the trade-offs, it changes the calculation."

The Uncomfortable Parallel

Military sonar prioritized performance over comfort because mission success was measurable and critical. Hearing aids prioritize comfort over performance because returns are measurable and costly.

"The irony," Pendergast observes, "is that hearing aid users are trying to accomplish their mission too—understanding conversation in difficult acoustic environments. But manufacturers optimize for the easy scenarios and call it 'advanced technology.'"

The multi-beam beamforming claims that impressed him initially? "Marketing language that obscures fundamental limitations. In radar, we'd call that performance specification fiction."

The technology to solve the overhead music problem exists in published research and has existed for decades. What's missing isn't engineering capability—it's the commercial will to tell users that better speech understanding requires accepting degraded music quality.

Until that changes, hearing aid users facing the cocktail party problem—or its overhead-music variant—are left with the same advice Pendergast received: "Try moving to a different seat."

Not exactly the solution military engineers would have accepted.

The adaptive notch filtering approach described here has been demonstrated in peer-reviewed research but is not available in any commercial hearing aid as of February 2026. Users interested in experimental devices should contact university hearing research laboratories.

Verified Sources and Citations

Primary Research Studies

Lin, F.R., et al. (2023). "Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): a multicentre, randomised controlled trial." The Lancet, 402(10404), 786-797. https://doi.org/10.1016/S0140-6736(23)01406-X
Yeo, B.S.Y., et al. (2023). "Association of Hearing Aids and Cochlear Implants With Cognitive Decline and Dementia: A Systematic Review and Meta-analysis." JAMA Neurology, 80(2), 134-141. https://doi.org/10.1001/jamaneurol.2022.4427
Livingston, G., et al. (2020). "Dementia prevention, intervention, and care: 2020 report of the Lancet Commission." The Lancet, 396(10248), 413-446. https://doi.org/10.1016/S0140-6736(20)30367-6

Industry Analysis and Product Reviews

HearingTracker. (2024). "Signia Integrated Xperience (IX) Hearing Aid Review." HearingTracker.com. https://www.hearingtracker.com/signia-ix-hearing-aids
AudiologyHQ. (2025). "Phonak Audeo Lumity vs Signia IX: Comprehensive Comparison." AudiologyHQ.com. https://www.audiologyhq.com/phonak-vs-signia-comparison
Consumer Reports. (2024). "How to Buy Hearing Aids: A Comprehensive Guide." ConsumerReports.org. https://www.consumerreports.org/health/hearing-aids/buying-guide/

Regulatory and Industry Information

U.S. Food and Drug Administration. (2024). "Hearing Aids: Regulatory Information." FDA.gov. https://www.fda.gov/medical-devices/consumer-products/hearing-aids
Federal Trade Commission. (2024). "Health Products Compliance Guidance." FTC.gov. https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance
American Academy of Audiology. (2024). "Clinical Practice Guidelines: Adult Hearing Screening." Audiology.org. https://www.audiology.org/practice-guidelines/

Manufacturer Information

WS Audiology. (2024). "Signia Integrated Xperience (IX) Platform Technical Specifications." Signia-pro.com. https://www.signia-pro.com/en-us/hearing-aids/signia-ix/
Phonak. (2024). "Audeo Lumity Product Information." Phonak.com. https://www.phonak.com/us/en/hearing-aids/phonak-audeo-lumity.html
hear.com. (2025). "Horizon IX Product Information and Pricing." hear.com. https://www.hear.com/hearing-aids/horizon/

Expert Commentary and Professional Organizations

Lin, F.R. (2024). "Hearing Loss and Cognitive Decline: What We Know and Don't Know." Johns Hopkins Bloomberg School of Public Health. https://publichealth.jhu.edu/hearing-and-cognition
American Speech-Language-Hearing Association. (2024). "The Effects of Hearing Loss on Cognitive Function." ASHA.org. https://www.asha.org/public/hearing/effects-of-hearing-loss/

Note on methodology: This analysis synthesizes peer-reviewed research, industry testing data, manufacturer specifications, and regulatory information current as of February 2026. Pricing reflects typical retail ranges; actual costs vary by provider and geographic location. All research citations verified through original sources.

Search This Blog

Science, Time, and Spirit

Horizon IX Hearing Aids